| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human actin related protein 2/3 complex, subunit 1B, 41kDa (ARPC1B) from ORIGENE TECHNOLOGIES | TP301103 | 20 ug | ORIGENE TECHNOLOGIES |
| Human actin related protein 2/3 complex, subunit 3, 21kDa (ARPC3) from ORIGENE TECHNOLOGIES | TP309711 | 20 ug | ORIGENE TECHNOLOGIES |
| Human actin related protein 2/3 complex, subunit 5, 16kDa (ARPC5) from ORIGENE TECHNOLOGIES | TP312631 | 20 ug | ORIGENE TECHNOLOGIES |
| Human actin related protein 2/3 complex, subunit 2, 34kDa (ARPC2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP300319 | 20 ug | ORIGENE TECHNOLOGIES |
| Human actin related protein 2/3 complex, subunit 4, 20kDa (ARPC4), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP760962 | 50 ug | ORIGENE TECHNOLOGIES |
| Human actin-related protein T2 (ACTRT2) from ORIGENE TECHNOLOGIES | TP306098 | 20 ug | ORIGENE TECHNOLOGIES |
| Human actin related protein M1 (ARPM1) from ORIGENE TECHNOLOGIES | TP303548 | 20 ug | ORIGENE TECHNOLOGIES |
| Human FSTL1 ELISA Kit from ORIGENE TECHNOLOGIES | EA100614 | 8x12 divisible strip | ORIGENE TECHNOLOGIES |
| GABA(A) receptor-associated protein (GABARAP) from ORIGENE TECHNOLOGIES | LY416054 | 100 ug | ORIGENE TECHNOLOGIES |
| GABA(A) receptor-associated protein like 1 (GABARAPL1) from ORIGENE TECHNOLOGIES | LY403111 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 21 (NUDT21) from ORIGENE TECHNOLOGIES | LY416262 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 18 (NUDT18) from ORIGENE TECHNOLOGIES | LY403033 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 5 (NUDT5) from ORIGENE TECHNOLOGIES | LY415472 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 8 (NUDT8) from ORIGENE TECHNOLOGIES | LY405550 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419314 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429104 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 16 (NUDT16), transcript variant 3 from ORIGENE TECHNOLOGIES | LY432610 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407737 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420095 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 16 (NUDT16), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407563 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403446 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 2 (NUDT2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY430174 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 22 (NUDT22), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426974 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 22 (NUDT22), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426975 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402086 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 6 (NUDT6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405102 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 4 (NUDT4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY412753 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402975 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 7 (NUDT7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426294 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405100 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 2A from ORIGENE TECHNOLOGIES | LY404632 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 3A from ORIGENE TECHNOLOGIES | LY404634 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 3A from ORIGENE TECHNOLOGIES | LY430776 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 22 (NUDT22), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410181 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 2B from ORIGENE TECHNOLOGIES | LY404633 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 4A from ORIGENE TECHNOLOGIES | LY404636 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 4A from ORIGENE TECHNOLOGIES | LY430778 | 100 ug | ORIGENE TECHNOLOGIES |
| Nudix (nucleoside diphosphate linked moiety X)-type motif 1 (NUDT1), transcript variant 2B from ORIGENE TECHNOLOGIES | LY430775 | 100 ug | ORIGENE TECHNOLOGIES |
| Cathepsin S (CTSS) from ORIGENE TECHNOLOGIES | LY401317 | 100 ug | ORIGENE TECHNOLOGIES |
| BMF - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409733 | 1 kit | ORIGENE TECHNOLOGIES |
| BMF Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH323634 | 10 ug | ORIGENE TECHNOLOGIES |
| Bmf - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN502189 | 1 kit | ORIGENE TECHNOLOGIES |
| B2M - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207587BN | 1 kit | ORIGENE TECHNOLOGIES |
| B2M - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207587 | 1 kit | ORIGENE TECHNOLOGIES |
| B2M - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207587RB | 1 kit | ORIGENE TECHNOLOGIES |
| B2M - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN207587LP | 1 kit | ORIGENE TECHNOLOGIES |
| B2M - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407587 | 1 kit | ORIGENE TECHNOLOGIES |
| B2m - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501908 | 1 kit | ORIGENE TECHNOLOGIES |
| HPCAL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403476 | 1 kit | ORIGENE TECHNOLOGIES |
| HPCAL4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405253 | 1 kit | ORIGENE TECHNOLOGIES |